Cantor Fitzgerald Downgrades Collegium Pharmaceutical (COLL) to Neutral
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $28.23 +0.28%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald analyst Brandon Folkes downgraded Collegium Pharmaceutical (NASDAQ: COLL) from Overweight to Neutral with a price target of $22.00.
For an analyst ratings summary and ratings history on Collegium Pharmaceutical click here. For more ratings news on Collegium Pharmaceutical click here.
Shares of Collegium Pharmaceutical closed at $24.84 yesterday.
You May Also Be Interested In
- Collegium Pharma (COLL) 2700 contracts of August 39 calls trade
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- UBS Downgrades ASX Limited (ASX:AU) (ASXFY) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
